Skip to main content

Peer Review reports

From: Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study

Original Submission
16 Dec 2021 Submitted Original manuscript
21 Dec 2021 Author responded Author comments - Junmei Jia
22 Dec 2021 Author responded Author comments - Junmei Jia
Resubmission - Version 2
21 Dec 2021 Submitted Manuscript version 2
16 Jan 2022 Reviewed Reviewer Report
18 Jan 2022 Reviewed Reviewer Report - Ullas Batra
19 Feb 2022 Author responded Author comments - Junmei Jia
Resubmission - Version 3
19 Feb 2022 Submitted Manuscript version 3
1 Mar 2022 Author responded Author comments - Junmei Jia
Resubmission - Version 4
1 Mar 2022 Submitted Manuscript version 4
4 Mar 2022 Author responded Author comments - Junmei Jia
Resubmission - Version 5
4 Mar 2022 Submitted Manuscript version 5
16 Mar 2022 Reviewed Reviewer Report - Ullas Batra
10 Apr 2022 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
11 Apr 2022 Editorially accepted
28 Apr 2022 Article published 10.1186/s12890-022-01951-x

You can find further information about peer review here.

Back to article page